The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.
Open accessAbstract
T cell proliferative responses to hepatitis B virus-encoded envelope antigen (S + preS2 + preS1), recombinant core antigen (HBcAg), and natural hepatitis B e antigen (HBeAg) were examined in 22 HBeAg-positive patients with chronic type B hepatitis and 17 healthy hepatitis B surface antigen (HBsAg) carriers. The results showed that HBeAg-positive patients had (a) higher levels of T cell responses to HBcAg/HBeAg than those of healthy HBsAg carriers (P less than 0.001 and P less than 0.01, respectively); (b) a further increase in these T cell responses during acute exacerbations (P less than 0.05 and P less than 0.05, respectively); (c) subsidence in the T cell responses to HBcAg/HBeAg after recovery from acute exacerbations and HBeAg seroconversion, whereas the responses would persist at high levels if the patients did not enter a clinical remission; and (d) low levels of T cell responses to S + preS2 + preS1 either before or after HBeAg seroconversion. The appearance of increasing T cell responses to HBcAg/HBeAg usually occurred in the early phase of acute exacerbations. These findings imply that HBcAg/HBeAg-specific T cells play an important role in the exacerbations of chronic hepatitis B and in HBeAg seroconversion. HBcAg/HBeAg-specific precursor T cell frequencies were serially studied in selected cases by limiting dilution assay. Elevation (two- to fourfold) of HBcAg/HBeAg-specific precursor T cell frequencies contributed to the increase of HBcAg/HBeAg-specific T cell proliferation during acute exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
PCR protocols — A guide to methods and applications
U.G. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90252-7 · Cited by 11,702
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Self-citationSeparation of leukocytes from blood and bone marrow
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 2,696
The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel Filtration
Mogensen, C. E. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076979 · Cited by 2,654
Taswell, C. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1614 · Cited by 1,212
Carman, W. F., Hadziyannis, S., Mcgarvey, M. J., Jacyna, M. R., Karayiannis, P., Makris, A., & Thomas, H. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90713-7 · Cited by 1,200
Release of Infectious Epstein-Barr Virus by Transformed Marmoset Leukocytes
Miller, G., & Lipman, M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.1.190 · Cited by 941
Perrillo, R. P., Schiff, E. R., Davis, G. L., Bodenheimer, H. C., Lindsay, K., Payne, J., Dienstag, J. L., O'Brien, C., Tamburro, C., Jacobson, I. M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008023230503 · Cited by 840
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Milich, D. R., Jones, J. E., Hughes, J. L., Price, J., Raney, A. K., & McLachlan, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6599 · Cited by 580
Ferrari, C., Penna, A., Bertoletti, A., Valli, A., Antoni, A. D., Giuberti, T., Cavalli, A., Petit, M. A., & Fiaccadori, F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3442 · Cited by 505
Chu, C.-M., Karayiannis, P., Fowler, M. J. F., Monjardino, J., Liaw, Y.-F., & Thomas, H. C. (1985) · Hepatology · doi:10.1002/hep.1840050315 · Cited by 419
Limiting dilution assays for the determination of immunocompetent cell frequencies.
Taswell, C. (1981) · Medical Entomology and Zoology · Cited by 395
Single step separation of human T and B cells using AET treated SRBC rosettes
Saxon, A., Feldhaus, J., & Robins, R. A. (1976) · Journal of Immunological Methods · doi:10.1016/0022-1759(76)90050-8 · Cited by 328
Spontaneous reactivation of chronic hepatitis B virus infection
Davis, G. L., Hoofnagle, J. H., & Waggoner, J. G. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90406-2 · Cited by 288
Immunochemical structure of hepatitis B e antigen in the serum.
Takahashi, K., Machida, A., Funatsu, G., Nomura, M., Usuda, S., Aoyagi, S., Tachibana, K., Miyamoto, H., Imai, M., Nakamura, T., et al. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.6.2903 · Cited by 216
Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.
Ferrari, C. I., Penna, A., Giuberti, T., Tong, M., Ribera, E., Fiaccadori, F., & Chisari, F. V. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.2050 · Cited by 157
Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum
Akahane, Y., Yamanaka, T., Suzuki, H., Sugai, Y., Tsuda, F., Yotsumoto, S., Omi, S., Okamoto, H., Miyakawa, Y., & Mayumi, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90632-b · Cited by 145
Ferrari, C. I., Mondelli, M. U., Penna, A., Fiaccadori, F., & Chisari, F. V. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.2.539 · Cited by 100
Hepatitis B Virus Infection, Its Sequelae, and Prevention in Taiwan
Chen, D. (1987) · Springer eBooks · doi:10.1007/978-4-431-68349-0_6 · Cited by 94
Self-citationHepatitis B virus structure and biology
Chisari, F. V., Ferrari, C. I., & Mondelli, M. U. (1989) · Microbial Pathogenesis · doi:10.1016/0882-4010(89)90073-9 · Cited by 87
Lee, P., Chang, M., Lee, C., Hsu, H., Chen, J.-S., Chen, P., & Chen, D. (1990) · Hepatology · doi:10.1002/hep.1840120406 · Cited by 67
Self-citationPurification and partial characterization of hepatitis e antigen (HBeAg)
Fields, H. A., Bradley, D. W., Davis, C. L., & Maynard, J. E. (1978) · Infection and Immunity · doi:10.1128/iai.20.3.792-803.1978 · Cited by 17
Akahane, Y., Suzuki, H., Sugai, Y., Tsuda, F., Yotsumoto, S., Omi, S., Okamoto, H., Miyakawa, Y., & Mayumi, M. (1990) · Cited by 17
Cited by
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Self-citationImmunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Management of hepatitis B: 2000—Summary of a workshop
Lok, A. S., Heathcote, E. J., & Hoofnagle, J. H. (2001) · Gastroenterology · doi:10.1053/gast.2001.24839 · Cited by 776
Management of hepatitis B: Summary of a clinical research workshop†
Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F. (2007) · Hepatology · doi:10.1002/hep.21627 · Cited by 628
Metadata
- Authors
- Tsai, S. L., Chen, P. J., Lai, M. Y., Yang, P. M., Sung, J. L., Huang, J. H., Hwang, L. H., Chang, T. H., & Chen, D. S.
- Venue
- Journal of Clinical Investigation
- Published
- 1992-01-01
- Volume
- 89
- Issue
- 1
- Pages
- 87-96
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2107451615
- Cited by
- 287
- References
- 24
- FWCI
- 11.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.